Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 2
2006 1
2007 4
2008 2
2009 1
2010 2
2011 1
2012 3
2013 8
2014 2
2015 7
2016 11
2017 11
2018 10
2019 10
2020 12
2021 16
2022 11
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 34491319

101 results

Results by year

Filters applied: . Clear all
Page 1
Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy.
Nauffal V, Marstrand P, Han L, Parikh VN, Helms AS, Ingles J, Jacoby D, Lakdawala NK, Kapur S, Michels M, Owens AT, Ashley EA, Pereira AC, Rossano JW, Saberi S, Semsarian C, Ware JS, Wittekind SG, Day S, Olivotto I, Ho CY. Nauffal V, et al. Eur Heart J. 2021 Oct 7;42(38):3932-3944. doi: 10.1093/eurheartj/ehab598. Eur Heart J. 2021. PMID: 34491319 Free PMC article.
Appropriate and inappropriate shocks in hypertrophic cardiomyopathy patients with subcutaneous implantable cardioverter-defibrillators: An international multicenter study.
Nazer B, Dale Z, Carrassa G, Reza N, Ustunkaya T, Papoutsidakis N, Gray A, Howell SJ, Elman MR, Pieragnoli P, Ricciardi G, Jacoby D, Frankel DS, Owens A, Olivotto I, Heitner SB. Nazer B, et al. Heart Rhythm. 2020 Jul;17(7):1107-1114. doi: 10.1016/j.hrthm.2020.02.008. Epub 2020 Feb 18. Heart Rhythm. 2020. PMID: 32084597 Free PMC article.
Strength of clinical indication and therapeutic impact of the implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy.
Fumagalli C, De Filippo V, Zocchi C, Tassetti L, Marra MP, Brunetti G, Baritussio A, Cipriani A, Bauce B, Carrassa G, Maurizi N, Zampieri M, Calore C, De Lazzari M, Berteotti M, Pieragnoli P, Corrado D, Olivotto I. Fumagalli C, et al. Int J Cardiol. 2022 Apr 15;353:62-67. doi: 10.1016/j.ijcard.2022.01.022. Epub 2022 Jan 12. Int J Cardiol. 2022. PMID: 35031346
Comparison of the new risk prediction model (HCM Risk-SCD) and classic risk factors for sudden death in patients with hypertrophic cardiomyopathy and defibrillator.
Ruiz-Salas A, García-Pinilla JM, Cabrera-Bueno F, Fernández-Pastor J, Peña-Hernández J, Medina-Palomo C, Barrera-Cordero A, De Teresa E, Alzueta J. Ruiz-Salas A, et al. Europace. 2016 May;18(5):773-7. doi: 10.1093/europace/euv079. Epub 2015 Apr 7. Europace. 2016. PMID: 25855675 Free article.
101 results